Literature DB >> 23674861

Portal vein stenosis after pancreatectomy following neoadjuvant chemoradiation therapy for pancreatic cancer.

Yosuke Tsuruga1, Hirofumi Kamachi, Kenji Wakayama, Tatsuhiko Kakisaka, Hideki Yokoo, Toshiya Kamiyama, Akinobu Taketomi.   

Abstract

Extrahepatic portal vein (PV) stenosis has various causes, such as tumor encasement, pancreatitis and as a post-surgical complication. With regard to post-pancreaticoduodenectomy, intraoperative radiation therapy with/without PV resection is reported to be associated with PV stenosis. However, there has been no report of PV stenosis after pancreatectomy following neoadjuvant chemoradiation therapy (NACRT). Here we report the cases of three patients with PV stenosis after pancreatectomy and PV resection following gemcitabine-based NACRT for pancreatic cancer and their successful treatment with stent placement. We have performed NACRT in 18 patients with borderline resectable pancreatic cancer since 2005. Of the 15 patients who completed NACRT, nine had undergone pancreatectomy. Combined portal resection was performed in eight of the nine patients. We report here three patients with PV stenosis, and thus the ratio of post-operative PV stenosis in patients with PV resection following NACRT is 37.5% in this series. We encountered no case of PV stenosis among 22 patients operated with PV resection for pancreatobiliary cancer without NACRT during the same period. A relationship between PV stenosis and NACRT is suspected, but further investigation is required to determine whether NACRT has relevance to PV stenosis.

Entities:  

Keywords:  Expandable metallic stent; Neoadjuvant chemoradiation therapy; Pancreatectomy; Pancreatic cancer; Portal vein stenosis

Mesh:

Year:  2013        PMID: 23674861      PMCID: PMC3646150          DOI: 10.3748/wjg.v19.i16.2569

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Authors:  Ross A Abrams; Andrew M Lowy; Eileen M O'Reilly; Robert A Wolff; Vincent J Picozzi; Peter W T Pisters
Journal:  Ann Surg Oncol       Date:  2009-04-24       Impact factor: 5.344

2.  Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.

Authors:  Hiroaki Ohigashi; Osamu Ishikawa; Hidetoshi Eguchi; Hidenori Takahashi; Kunihito Gotoh; Terumasa Yamada; Masahiko Yano; Akihiko Nakaizumi; Hiroyuki Uehara; Yoshihiko Tomita; Kinji Nishiyama
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

3.  Diagnosis and treatment of pediatric patients with late-onset portal vein stenosis after living donor liver transplantation.

Authors:  Youichi Kawano; Koichi Mizuta; Yasuhiko Sugawara; Satoshi Egami; Shuji Hisikawa; Yukihiro Sanada; Takehito Fujiwara; Yasunaru Sakuma; Masanobu Hyodo; Yoshiyuki Yoshida; Yoshikazu Yasuda; Eiji Sugimoto; Hideo Kawarasaki
Journal:  Transpl Int       Date:  2009-08-03       Impact factor: 3.782

4.  Percutaneous transhepatic balloon dilation of portal venous stenosis in patients with living donor liver transplantation.

Authors:  Toyomichi Shibata; Kyo Itoh; Takeshi Kubo; Yoji Maetani; Toshiya Shibata; Kaori Togashi; Koichi Tanaka
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

5.  Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.

Authors:  Cristina R Ferrone; Rafael Pieretti-Vanmarcke; Jordan P Bloom; Hui Zheng; Jackye Szymonifka; Jennifer A Wargo; Sarah P Thayer; Gregory Y Lauwers; Vikram Deshpande; Mari Mino-Kenudson; Carlos Fernández-del Castillo; Keith D Lillemoe; Andrew L Warshaw
Journal:  Surgery       Date:  2012-07-03       Impact factor: 3.982

6.  Stent placement for portal venous stenosis following major abdominal surgery.

Authors:  Haruyuki Takaki; Koichiro Yamakado; Atsuhiro Nakatsuka; Junji Uraki; Masanobu Usui; Hiroyuki Sahurai; Shuji Isaji; Kan Takeda
Journal:  Hepatogastroenterology       Date:  2009 Mar-Apr

7.  Endovascular recanalization of symptomatic portomesenteric venous obstruction after pancreaticoduodenectomy and radiation.

Authors:  Eric K Hoffer; Steven Krohmer; John Gemery; Bassem Zaki; J Marc Pipas
Journal:  J Vasc Interv Radiol       Date:  2009-10-24       Impact factor: 3.464

8.  Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.

Authors:  S D Leach; J E Lee; C Charnsangavej; K R Cleary; A M Lowy; C J Fenoglio; P W Pisters; D B Evans
Journal:  Br J Surg       Date:  1998-05       Impact factor: 6.939

9.  Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.

Authors:  Douglas B Evans; Gauri R Varadhachary; Christopher H Crane; Charlotte C Sun; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Huamin Wang; Karen R Cleary; Gregg A Staerkel; Chusilp Charnsangavej; Elizabeth A Lano; Linus Ho; Renato Lenzi; James L Abbruzzese; Robert A Wolff
Journal:  J Clin Oncol       Date:  2008-07-20       Impact factor: 44.544

10.  Portal vein venoplasty and stent placement in the nontransplant population.

Authors:  David A Woodrum; Haraldur Bjarnason; James C Andrews
Journal:  J Vasc Interv Radiol       Date:  2009-03-31       Impact factor: 3.464

View more
  6 in total

1.  Stent Placement for Portal Vein Stenosis After Pancreaticoduodenectomy.

Authors:  Masahide Hiyoshi; Yoshiro Fujii; Kazuhiro Kondo; Naoya Imamura; Motoaki Nagano; Jiro Ohuchida
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

2.  Benign Portal Vein Stenosis After Pancreaticoduodenectomy.

Authors:  Katsuhisa Ohgi; Teiichi Sugiura; Yusuke Yamamoto; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

3.  Long-term efficacy and risk factors for stent occlusion in portal vein stent placement: a multi-institutional retrospective study.

Authors:  Hirotsugu Nakai; Hironori Shimizu; Takanori Taniguchi; Seiya Kawahara; Toshihide Yamaoka; Naoya Sasaki; Hiroyoshi Isoda; Yuji Nakamoto
Journal:  CVIR Endovasc       Date:  2022-06-16

4.  Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer.

Authors:  Eric A Mellon; Tobin J Strom; Sarah E Hoffe; Jessica M Frakes; Gregory M Springett; Pamela J Hodul; Mokenge P Malafa; Michael D Chuong; Ravi Shridhar
Journal:  J Gastrointest Oncol       Date:  2016-08

5.  Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?

Authors:  Hiroki Sato; Junichi Soh; Katsuyuki Hotta; Kuniaki Katsui; Susumu Kanazawa; Katsuyuki Kiura; Shinichi Toyooka
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-04-20       Impact factor: 1.520

6.  Portal Vein Stenting for Jejunal Variceal Bleeding after Recurrence of Pancreatic Adenocarcinoma: A Case Report and Review of the Literature.

Authors:  Seiichiro Takao; Masakazu Hirakawa; Kazuki Takeishi; Yushi Motomura; Katsumi Sakamoto; Hajime Otsu; Yusuke Yonemura; Koshi Mimori; Kousei Ishigami
Journal:  Interv Radiol (Higashimatsuyama)       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.